Fig. 3From: The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019Estimates of βk from 2-way fixed-effects premature mortality models [Eq. (3)] Solid squares denote significant (p value < .05) estimates; hollow squares denote insignificant estimatesBack to article page